COMMUNIQUÉS West-GlobeNewswire

-
BioTelemetry, Inc. Acquires Sweden-based ADEA Medical AB and Expands International Service Offering
24/07/2019 -
Novan’s Drug Substance Demonstrates Inhibition of HPV-18 Virus Production
24/07/2019 -
Ziopharm Oncology Names Sath Shukla as Chief Financial Officer
24/07/2019 -
Foamix Pharmaceuticals to Report Second Quarter 2019 Financial Results on August 8
24/07/2019 -
Miragen Therapeutics to Report Second Quarter 2019 Financial Results and Host a Conference Call on August 7th
24/07/2019 -
HTG Molecular Diagnostics to Announce Second Quarter 2019 Financial Results and Host Conference Call on Tuesday, August 6
24/07/2019 -
Surgery Partners, Inc. Announces Second Quarter 2019 Earnings Release Date and Conference Call Details
24/07/2019 -
Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid Leukemia
24/07/2019 -
Synthorx Initiates Patient Dosing in Australia and Announces Clearance of IND in the U.S. for Lead Immuno-oncology Product Candidate, THOR-707
24/07/2019 -
Chembio Diagnostics to Report Second Quarter 2019 Financial Results on August 6, 2019
24/07/2019 -
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
24/07/2019 -
NeuBase Therapeutics Appoints Danith Ly, Ph.D. as Chief Scientific Officer
24/07/2019 -
Cannabis Suisse Corp. is Happy to Announce the Launching of a New Product in Our Retail Brand Alpine Cannabis
24/07/2019 -
Julie Stephenson Joins BioSig as Senior Director of Clinical Affairs
24/07/2019 -
Obalon Announces Second Quarter 2019 Financial Results
24/07/2019 -
Strongbridge Biopharma plc to Host Second Quarter 2019 Financial Results Conference Call on July 31, 2019
24/07/2019 -
Microbot Medical Receives Notice of Allowance from the Israel Patent Office for a Patent Application covering a System for Reducing Dialysis Shunt Stenosis
24/07/2019 -
T2 Biosystems Announces 2019 Second Quarter Financial and Operational Results Release and Conference Call Date
24/07/2019 -
Kura Oncology’s Menin-MLL Inhibitor KO-539 Receives Orphan Drug Designation from FDA for Treatment of Acute Myeloid Leukemia
24/07/2019
Pages